ACVC Premium Access

Controversies on anticoagulants post-MI antithrombotic treatment

Event: Acute Cardiovascular Care 2018
Topic: Acute Coronary Syndromes: Post-Infarction Period
Session type: Debate Session
Date: 3 March 2018
Time: 14:00 - 15:30

Session

10 presentations in this session

Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - PRO.

Speaker: Doctor A. Rubboli (Ravenna, IT)
Thumbnail

Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - CONTRA.

Speaker: Professor R. Storey (Sheffield, GB)
Thumbnail

Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - Rebuttal PRO.

Speaker: Doctor A. Rubboli (Ravenna, IT)
Thumbnail

Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - Rebuttal CONTRA.

Speaker: Professor R. Storey (Sheffield, GB)
Thumbnail

Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough: Chairpersons conclusion

Thumbnail

All stented patients with atrial fibrillation, stable one year after intervention, should be managed with oral anticoagulants, without antiplatelets - PRO.

Speaker: Professor R. De Caterina (Pisa, IT)
Thumbnail

All stented patients with atrial fibrillation, stable one year after intervention, should be managed with oral anticoagulants, without antiplatelets - CONTRA.

Speaker: Professor C. Granger (Durham, US)
Thumbnail

All stented patients with atrial fibrillation, stable one year after intervention, should be managed with oral anticoagulants, without antiplatelets - Rebuttal PRO.

Speaker: Professor R. De Caterina (Pisa, IT)
Thumbnail

All stented patients with atrial fibrillation, stable one year after intervention, should be managed with oral anticoagulants, without antiplatelets - Rebuttal CONTRA.

Speaker: Professor C. Granger (Durham, US)
Thumbnail

All stented patients with atrial fibrillation, stable one year after intervention, should be managed with oral anticoagulants: Chairpersons conclusion.

Thumbnail

8 speakers from this session

Doctor Andrea Rubboli

Santa Maria delle Croci Hospital, Ravenna (Italy)
12 presentations
0 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

Doctor Andrea Rubboli

Santa Maria delle Croci Hospital, Ravenna (Italy)
12 presentations
0 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)
25 presentations
1 follower

Professor Christopher B Granger

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
11 presentations
0 follower

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)
25 presentations
1 follower

Professor Christopher B Granger

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
11 presentations
0 follower

This platform is supported by

logo Novo Nordisk